financetom
Business
financetom
/
Business
/
J&J Snack Foods Fiscal Q1 Adjusted Earnings Decline, Sales Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
J&J Snack Foods Fiscal Q1 Adjusted Earnings Decline, Sales Rise
Feb 3, 2025 2:01 PM

04:38 PM EST, 02/03/2025 (MT Newswires) -- J&J Snack Foods ( JJSF ) reported fiscal Q1 adjusted earnings late Monday of $0.33 per diluted share, down from $0.52 a year earlier.

Analysts polled by FactSet expected $0.59.

Net sales in the three months ended Dec. 28 rose to $362.6 million from $348.3 million a year earlier.

Analysts surveyed by FactSet expected $360.9 million.

The company's shares fell 4.1% in recent after-hours trading.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
MGP Ingredients Names Julie Francis as President, CEO
MGP Ingredients Names Julie Francis as President, CEO
Jul 21, 2025
08:27 AM EDT, 07/21/2025 (MT Newswires) -- MGP Ingredients ( MGPI ) said Monday its board appointed Julie Francis as the company's president and chief executive officer, effective immediately. Francis takes over from Interim President and CEO Brandon Gall, who served in the role since January 1 and will continue as the company's chief financial officer, according to a statement....
Digi Power X to Raise $15 Million in Registered Direct Offering; Shares Down
Digi Power X to Raise $15 Million in Registered Direct Offering; Shares Down
Jul 21, 2025
08:26 AM EDT, 07/21/2025 (MT Newswires) -- Digi Power X ( DGXX ) said Monday that it has agreed to sell 4.8 million shares at $3.12 each to a new institutional investor in a registered direct offering. The offering is slated to be completed on or around Tuesday, subject to TSX Venture Exchange approval and customary conditions, the company said....
Sarepta Therapeutics Says US FDA Places Clinical Hold on Gene Therapy Trials for Limb-Girdle Muscular Dystrophy
Sarepta Therapeutics Says US FDA Places Clinical Hold on Gene Therapy Trials for Limb-Girdle Muscular Dystrophy
Jul 21, 2025
08:25 AM EDT, 07/21/2025 (MT Newswires) -- Sarepta Therapeutics ( SRPT ) said Monday in a regulatory filing the US Food and Drug Administration has placed a clinical hold on its gene therapy trials for limb-girdle muscular dystrophy. The hold includes the company's LGMD clinical trials related to its therapeutic candidates SRP-9003, SRP-9004, SRP-6004, and SRP-9005, the company said. Sarepta...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved